Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CTSN Embolic Protection Trial

NCT: NCT06027788 · RECRUITING

NCT IDNCT06027788
StatusRECRUITING
Start Date2023-09-18
Completion2027-04-01

Brief Summary

This is a prospective, multi-center, randomized effectiveness trial of the CardioGard Embolic Protection Cannula in high-risk valve surgery patients.

Frequently Asked Questions

What is CTSN Embolic Protection Trial?

CTSN Embolic Protection Trial is a clinical trial registered under NCT06027788. Current status: RECRUITING.

What is the status of NCT06027788?

The current status of NCT06027788 (CTSN Embolic Protection Trial) is: RECRUITING.

When did CTSN Embolic Protection Trial start?

CTSN Embolic Protection Trial started on 2023-09-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑